Innovation

Insilico Medicine’s Precious3GPT Advances AI For Longevity

 
• By 

InSilico Medicine hopes its open-source LLM will be the “one model to guide them all” as industry moves towards artificial biomedical intelligence and interest in longevity grows.

How To Create Organizational Readiness for AI

 
• By 

The time is now to prepare your company for AI implementation. Doing so starts with the C-suite.

Radiopharmaceutical Strategies Begin To Take Shape As Field Rolls Into 2025

 
• By 

Radioligand therapies offer a resistance-proof mechanism that complements immuno-therapies and other drug classes. No wonder oncology players continue to pile in.

AI Starts To Make Its Mark In Pharma Marketing

 

The early adoption of artificial intelligence/machine learning has centered around drug discovery, but the technologies are being applied to other fields, including pharma marketing.


New Manufacturing Technologies Are Here – What's Stopping Their Implementation?

 

Pharmaceutical manufacturing is developing at a lightning pace as the confluence of automation and AI creates opportunities for much higher efficiency and throughput. Experts from across the industry discuss these, and the challenges around implementation and standardization.

Big Pharma GCCs In India: From Back-Office Ops To Innovation Catalysts

 

India is seeing a flurry of activity with big pharma either establishing or expanding their global capability centers in the country. Can these hubs reshape the contours of industry’s operating model across a range of functions and perhaps spawn a pipeline of new leaders along the way?

Podcast: Mapping The Immune System To Predict Immune Responses

 
• By 

Israeli-American biotech Immunai is mapping the immune system and using AI to predict immune responses to drugs.

The Future Of Inflammation: The Inflammasome And Beyond

 
• By 

Novel targets for managing inflammation hold the promise of greater efficacy and safety for diseases not widely viewed as inflammatory in nature.


ATMP Manufacturing: Complex Challenges Require Complex Solutions

 

Experts working in the advanced therapy sector tell In Vivo how novel solutions can empower cell and gene therapy manufacturers to reduce costs, improve scalability and optimize their processes – improving the clinical profile and commercial viability of products.

Neoadjuvant Cancer Immunotherapy Set For Takeoff, Fueled By Strong Data

 
• By 

Dreams of a future with early curative treatments drives wave of drug development in pre-surgical and perioperative treatment in many tumor types.

The Practice-Changing Drugs That Will Graduate In 2025

 
• By 

A wealth of new therapies are set to successfully graduate from the pipeline in 2025. Within this cohort are a mixture of therapeutic areas, drug classes, first-time approvals, label expansions, and treatments that will meaningfully change how diseases are treated.

Korea Lays Out Roadmap For Use Of AI Across Drug Development

 
• By 

The five-year roadmap aims to expand support for AI research and development in essential health care and new drug development, as well as advance medical data usage systems and enable its safe use.


Transnational Collaborative Health Tech Assessments Have Much To Offer

 

European cross-border HTA collaborations have much to learn from each other to keep drug prices from rising unfairly, say Nordic health technology assessment experts. Talks on HTA collaborations outside Europe are also underway.

Google’s New Drug Discovery And Development LLM

 
• By 

A new large language model by Google Research and DeepMind is the most comprehensive tool yet to potentially expedite drug development and reduce the risk of failure.

A Race Against Time: Diagnostics Is Key To Tackling AMR

 

Charles Cooper, CMO of the diagnostics firm bioMérieux, talks to In Vivo about the vital nature of partnerships to fight the global AMR crisis.

Double Jeopardy: Brightening The Outlook For Women With Rare Liver Disease

 
• By 

Ipsen rare diseases head Jennifer Schranz talks to In Vivo about why women are especially susceptible to a “diagnostic odyssey,” and how the company is working to find and treat female zebras.


Roche Uses Its CGM To Target Unmet Needs In Diabetes Control

 
• By 

CE marking for its Accu-Chek Smartguide continuous glucose monitor means Roche is on the cusp of challenging existing major players in Europe with a device whose predictive algorithms can help sufferers plan and prepare longer into the future.

From PhD To Unicorn: Mammoth CEO On Pharma Deals and Squishy Biology

 
• By 

Trevor Martin talked to In Vivo about the importance of sharing a strategic vision with partners, the company’s superpower, and how a PhD is the best prep for a startup.

FDA Publishes Updated Roadmap For Advancing Women’s Health

 

The US FDA’s Office of Women’s Health provides a research roadmap to address health concerns specific to women. The FDA recently updated the roadmap, outlining areas in which further research is needed.

Fusion CEO Talks AZ Deal Making And Canada’s Blossoming Biotech Ecosystem

 
• By 

Fusion Pharmaceuticals Inc CEO John Valliant talked to In Vivo about Canadian leadership in radiopharmaceutical innovation, its differentiated approach, and excitement around combination therapies for precision cancer treatments.